Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Enhances Rituximab-Induced Death and Chemosensitization in B-Cell Lymphoma. This evidence concerns the gene PEBP4 and B-cell non-Hodgkin lymphoma.